{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:12:18Z","timestamp":1790874738562,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS","doi-asserted-by":"publisher","award":["15K08790"],"award-info":[{"award-number":["15K08790"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.autrev.2019.05.002","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T11:44:45Z","timestamp":1556883885000},"page":"658-664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Anti-OJ autoantibodies: Rare or underdetected?"],"prefix":"10.1016","volume":"18","author":[{"given":"Jean-Baptiste","family":"Vulsteke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore","family":"Malyavantham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bossuyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"De Langhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2019.05.002_bb0005","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamaneurol.2017.0934","article-title":"Skeletal muscle involvement in antisynthetase syndrome","volume":"74","author":"Noguchi","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0010","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2019.05.002_bb0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.autrev.2014.01.022","article-title":"Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review","volume":"13","author":"Mahler","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.05.002_bb0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13075-017-1469-8","article-title":"Correction: identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study","volume":"19","author":"Yang","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2019.05.002_bb0025","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2019.05.002_bb0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/jamaneurol.2017.3872","article-title":"New criteria needed for antisynthetase syndrome","volume":"75","author":"Casta\u00f1eda","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0035","first-page":"e1144","article-title":"Clinical spectrum time course in anti jo-1 positive antisynthetase syndrome: Results from an international retrospective multicenter study","volume":"94","author":"Cavagna","year":"2015","journal-title":"Med (United States)"},{"key":"10.1016\/j.autrev.2019.05.002_bb0040","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.40063","article-title":"Editorial: a new classification of adult autoimmune myositis","volume":"69","author":"Sen\u00e9cal","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0045","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","article-title":"Autoantibodies in myositis","volume":"14","author":"McHugh","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0050","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0055","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.4049\/jimmunol.144.5.1737","article-title":"Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis","volume":"144","author":"Targoff","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0060","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1172\/JCI116493","article-title":"Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase","volume":"91","author":"Targoff","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2019.05.002_bb0065","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1021\/bi00418a038","article-title":"Structural organization of the multienzyme complex of mammalian aminoacyl-tRNA synthetases","volume":"27","author":"Godar","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.autrev.2019.05.002_bb0070","series-title":"Macromol. Protein Complexes, Struct. Funct.","first-page":"505","article-title":"The aminoacyl-tRNA synthetase complex","volume":"83","author":"Mirande","year":"2017"},{"key":"10.1016\/j.autrev.2019.05.002_bb0075","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.1780390424","article-title":"Coexistence of two antisynthetases in a patient with the antisynthetase syndrome","volume":"39","author":"Gelp\u00ed","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.05.002_bb0080","doi-asserted-by":"crossref","first-page":"7912","DOI":"10.1073\/pnas.122110199","article-title":"p38 is essential for the assembly and stability of macromolecular tRNA synthetase complex: implications for its physiological significance","volume":"99","author":"Kim","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2019.05.002_bb0085","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1093\/nar\/gky211","article-title":"A threonyl-tRNA synthetase-like protein has tRNA aminoacylation and editing activities","volume":"46","author":"Chen","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.autrev.2019.05.002_bb0090","doi-asserted-by":"crossref","first-page":"e81734","DOI":"10.1371\/journal.pone.0081734","article-title":"Reinvestigation of aminoacyl-TRNA synthetase core complex by affinity purification-mass spectrometry reveals TARSL2 as a potential member of the complex","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2019.05.002_bb0095","doi-asserted-by":"crossref","first-page":"38870","DOI":"10.1074\/jbc.M502759200","article-title":"A three-dimensional working model of the multienzyme complex of aminoacyl-tRNA synthetases based on electron microscopic placements of tRNA and proteins","volume":"280","author":"Wolfe","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2019.05.002_bb0100","doi-asserted-by":"crossref","first-page":"23979","DOI":"10.1074\/jbc.M113.489922","article-title":"Small-angle X-ray solution scattering study of the multi-aminoacyl-tRNA synthetase complex reveals an elongated and multi-armed particle","volume":"288","author":"Dias","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2019.05.002_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2016.02.017","article-title":"Testing for myositis specific autoantibodies: comparison between line blot and immunoprecipitation assays in 57 myositis sera","volume":"433","author":"Cavazzana","year":"2016","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.autrev.2019.05.002_bb0110","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/14397595.2016.1213947","article-title":"Comparison of anti-OJ antibody detection assays between an immunoprecipitation assay and line blot assay","volume":"27","author":"Hamaguchi","year":"2017","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0115","doi-asserted-by":"crossref","first-page":"909","DOI":"10.6061\/clinics\/2013(07)04","article-title":"Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis","volume":"68","author":"Cruellas","year":"2013","journal-title":"Clinics"},{"key":"10.1016\/j.autrev.2019.05.002_bb0120","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1136\/annrheumdis-2017-212915","article-title":"Detection of myositis-specific antibodies","volume":"78","author":"Vulsteke","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.05.002_bb0125","article-title":"Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies","author":"Zampeli","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0085062","article-title":"The multicenter study of a new assay for simultaneous detection of multiple anti-aminoacyl-tRNA synthetases in myositis and interstitial pneumonia","volume":"9","author":"Nakashima","year":"2014","journal-title":"PLoS One"},{"issue":"848","key":"10.1016\/j.autrev.2019.05.002_bb0135","article-title":"Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies","volume":"10","author":"Mahler","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0140","doi-asserted-by":"crossref","first-page":"444.1","DOI":"10.3899\/jrheum.170258","article-title":"The antinuclear antibody test in the diagnosis of antisynthetase syndrome and other autoimmune myopathies","volume":"45","author":"Fritzler","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2169\/internalmedicine.49.2889","article-title":"Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies","volume":"49","author":"Koreeda","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2019.05.002_bb0150","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.2169\/internalmedicine.51.7452","article-title":"The clinical characteristics of two anti-OJ (anti-Isoleucyl-tRNA Synthetase) autoantibody-positive interstitial lung disease patients with polymyositis\/dermatomyositis","volume":"51","author":"Kunimasa","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2019.05.002_bb0155","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0049-0172(96)80026-6","article-title":"Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis","volume":"26","author":"Friedman","year":"1996","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.05.002_bb0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ymeth.2016.09.017","article-title":"Nonconventional localizations of cytosolic aminoacyl-tRNA synthetases in yeast and human cells","volume":"113","author":"Debard","year":"2017","journal-title":"Methods"},{"key":"10.1016\/j.autrev.2019.05.002_bb0165","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/ar2548","article-title":"Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies","volume":"10","author":"Mahler","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2019.05.002_bb0170","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3899\/jrheum.160618","article-title":"Negative antinuclear antibody does not indicate autoantibody negativity in myositis: role of anticytoplasmic antibody as a screening test for antisynthetase syndrome","volume":"44","author":"Aggarwal","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060442","article-title":"Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA Synthetase antibodies: heterogeneity within the syndrome","volume":"8","author":"Hamaguchi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2019.05.002_bb0180","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/rheumatology\/ker132","article-title":"Anti-synthetase syndrome positive for anti-isoleucyl-tRNA synthetase antibodies: an unusual case overlapping with systemic sclerosis and Sjogren's syndrome","volume":"50","author":"Hervier","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2019.05.002_bb0185","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/14397595.2015.1014137","article-title":"Juvenile polymyositis associated with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody in a 13-year-old girl","volume":"27","author":"Hamada","year":"2017","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0190","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","article-title":"Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody","volume":"41","author":"Marie","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.002_bb0195","doi-asserted-by":"crossref","first-page":"e000661","DOI":"10.1136\/rmdopen-2018-000661","article-title":"Prevalence and clinical correlates of rheumatoid factor and anticitrullinated protein antibodies in patients with idiopathic inflammatory myopathy","volume":"4","author":"Ide","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2019.05.002_bb0200","first-page":"999","article-title":"A longitudinal cohort study of the anti-synthetase syndrome: Increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies","volume":"56","author":"Pinal-Fernandez","year":"2017","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.autrev.2019.05.002_bb0205","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","article-title":"Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients","volume":"73","author":"Aggarwal","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.05.002_bb0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.rmed.2016.12.014","article-title":"Interstitial lung disease and myositis-specific and associated autoantibodies: clinical manifestations, survival and the performance of the new ATS\/ERS criteria for interstitial pneumonia with autoimmune features (IPAF)","volume":"123","author":"Mej\u00eda","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2019.05.002_bb0215","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/1529-0131(199809)41:9<1625::AID-ART13>3.0.CO;2-D","article-title":"Spectrum and clinical significance of autoantibodies against transfer RNA","volume":"41","author":"Ohosone","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.05.002_bb0220","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/rheumatology\/kel435","article-title":"Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies","volume":"46","author":"Sato","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2019.05.002_bb0225","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00296-010-1695-8","article-title":"Dermatomyositis with anti-OJ antibody","volume":"31","author":"Noda","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2019.05.002_bb0230","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.rmed.2014.09.003","article-title":"Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type","volume":"108","author":"Johnson","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2019.05.002_bb0235","first-page":"712","article-title":"Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1\/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis","volume":"57","author":"Pauling","year":"2018","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.autrev.2019.05.002_bb0240","first-page":"4","article-title":"Novel case of anti-synthetase syndrome","author":"Kapoor","year":"2018","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0245","first-page":"1012","article-title":"Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis","volume":"34","author":"Matsushita","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0250","doi-asserted-by":"crossref","DOI":"10.1007\/s00408-018-0108-8","article-title":"Prevalence of myositis-specific antibodies in idiopathic interstitial pneumonias","author":"De Sadeleer","year":"2018","journal-title":"Lung"},{"key":"10.1016\/j.autrev.2019.05.002_bb0255","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1097\/MD.0000000000000523","article-title":"In antisynthetase syndrome, ACPA are associated with severe and erosive arthritis: an overlapping rheumatoid arthritis and antisynthetase syndrome","volume":"94","author":"Meyer","year":"2015","journal-title":"Med"},{"key":"10.1016\/j.autrev.2019.05.002_bb0260","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10067-010-1666-1","article-title":"A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept","volume":"30","author":"Ishikawa","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0265","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00296-011-1931-x","article-title":"High frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis","volume":"32","author":"Nakajima","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2019.05.002_bb0270","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an american college of rheumatology\/European league against rheumatism collaborative initiative","volume":"65","author":"Van Den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.05.002_bb0275","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/art.1780230802","article-title":"Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system","volume":"23","author":"Nishikai","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.05.002_bb0280","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1084\/jem.163.5.1281","article-title":"Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis","volume":"163","author":"Bunn","year":"1986","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2019.05.002_bb0285","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/rheumatology\/kep455","article-title":"Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases","volume":"49","author":"Hervier","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2019.05.002_bb0290","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1084\/jem.160.2.420","article-title":"Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody","volume":"160","author":"Mathews","year":"1984","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2019.05.002_bb0295","first-page":"206","article-title":"Anti-PL-7 (Anti-Threonyl-tRNA synthetase) Antisynthetase syndrome: clinical manifestations in a series of patients from a european multicenter study (EUMYONET) and review of the literature","volume":"91","author":"Labirua-Iturburu","year":"2012","journal-title":"Med (United States)"},{"key":"10.1016\/j.autrev.2019.05.002_bb0300","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.4049\/jimmunol.162.4.2315","article-title":"Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease","volume":"162","author":"Hirakata","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0305","article-title":"Anti-KS autoantibody is associated with sicca syndrome and interstitial lung disease","volume":"1540","author":"Kondo","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 9","key":"10.1016\/j.autrev.2019.05.002_bb0310","article-title":"Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with anti-synthetase syndrome","volume":"52","author":"Hashish","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.05.002_bb0315","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/rheumatology\/kem045","article-title":"Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia","volume":"46","author":"Betteridge","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2019.05.002_bb0320","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0014-4827(91)90501-K","article-title":"Tryptophanyl-tRNA synthetase in cell lines resistant to tryptophan analogs","volume":"195","author":"Paley","year":"1991","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.autrev.2019.05.002_bb0325","first-page":"1033","article-title":"Detection of autoantibodies against phenylalanyl-, tyrosyl-, and tryptophanyl-tRNA-synthetase and anti-idiotypic antibodies to it in serum from patients with autoimmune diseases","volume":"25","author":"Vartanian","year":"1991","journal-title":"Mol Biol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0330","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0165-2478(95)02469-7","article-title":"Tryptophanyl-tRNA synthetase as a human autoantigen","volume":"48","author":"Paley","year":"1995","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2019.05.002_bb0335","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.89.20.9739","article-title":"Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion","volume":"89","author":"Gelpi","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2019.05.002_bb0340","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.05.002_bb0345","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1172\/JCI114136","article-title":"Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease","volume":"84","author":"Targoff","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2019.05.002_bb0350","first-page":"373","article-title":"A novel autoantibody reactive with a 48 kDa tRNA associated protein in patients with scleroderma","volume":"18","author":"Miyachi","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0355","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3109\/s10165-011-0582-9","article-title":"NEFA\/nucleobindin-2 is a target autoantigen of the anti-Wa antibody and is associated with transfer RNA","volume":"22","author":"Imura","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2019.05.002_bb0360","first-page":"105","article-title":"Cellular protein and RNA antigens in autoimmune disease","volume":"2","author":"Bernstein","year":"1984","journal-title":"Mol Biol Med"},{"key":"10.1016\/j.autrev.2019.05.002_bb0365","first-page":"S81","article-title":"The polymyositis-associated Fer antigen is elongation factor Ia","volume":"32","author":"Targoff","year":"1989","journal-title":"Arthritis Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219301041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219301041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:16:32Z","timestamp":1761599792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997219301041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":73,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1568997219301041"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2019.05.002","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-OJ autoantibodies: Rare or underdetected?","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2019.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}